Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size

Partner-Specific HIV Risk Reduction Intervention for Drug-Using Adolescents (GET UP)

This study has been completed.
Sponsor:
Collaborator:
University of Rhode Island
Information provided by (Responsible Party):
Cynthia Rosengard, Women and Infants Hospital of Rhode Island
ClinicalTrials.gov Identifier:
NCT00831883
First received: January 28, 2009
Last updated: December 3, 2012
Last verified: December 2012
History of Changes

January 28, 2009
December 3, 2012
February 2009
January 2011   (final data collection date for primary outcome measure)
lower levels of sex-related HIV risk behavior [ Time Frame: 3 months ] [ Designated as safety issue: No ]
lower levels of sex-related HIV risk behavior [ Time Frame: 3 months & 6 months ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT00831883 on ClinicalTrials.gov Archive Site
  • knowledge about STI transmission [ Time Frame: 3 months ] [ Designated as safety issue: No ]
  • partner-specific perceptions of STI risks [ Time Frame: 3 months ] [ Designated as safety issue: No ]
  • social norms, expectations and personal attitudes regarding partner-specific sexual behavior [ Time Frame: 3 months ] [ Designated as safety issue: No ]
  • partner-specific behavioral and communication skills [ Time Frame: 3 months ] [ Designated as safety issue: No ]
  • knowledge about STI transmission [ Time Frame: 3 months & 6 months ] [ Designated as safety issue: No ]
  • partner-specific perceptions of STI risks [ Time Frame: 3 months & 6 months ] [ Designated as safety issue: No ]
  • social norms, expectations and personal attitudes regarding partner-specific sexual behavior [ Time Frame: 3 months & 6 months ] [ Designated as safety issue: No ]
  • partner-specific behavioral and communication skills [ Time Frame: 3 months & 6 months ] [ Designated as safety issue: No ]
Not Provided
Not Provided
 
Partner-Specific HIV Risk Reduction Intervention for Drug-Using Adolescents
Partner-Specific HIV Risk Reduction Intervention for Drug-Using Incarcerated Adolescents
The purpose of this study is to develop and pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use.
Incarcerated adolescents represent a group at high risk for health consequences associated with risky sexual behaviors. Condom use is more common with non-main than main sex partners and substance use in conjunction with sexual risk also appears to vary by partner type. The research team will conduct a small randomized trial to pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use. Participants will be randomized to a 5 session HIV risk reduction group intervention based on the Information-Motivation-Behavioral Skills model, or a 5 session healthy lifestyles psychoeducation intervention, and then reassessed 3 months after their access to the general community is reinstated. The main hypothesis is that participants in the HIV risk reduction intervention condition will have lower levels of sex-related HIV risk behavior and of substance use in conjunction with sexual risk, relative to those in a healthy lifestyles psychoeducation intervention.
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Prevention
  • Sexually Transmitted Diseases
  • Substance-Related Disorders
  • Behavioral: Partner-Specific IMB-based HIV risk reduction intervention
    5 session partner-specific HIV risk reduction group intervention based on the Information-Motivation-Behavioral Skills model.
  • Behavioral: Healthy Lifestyle
    5 session psychoeducational group, designed to provide equivalent time and attention, that focuses on the importance of maintaining a good diet, exercise, and developing health skills.
  • Experimental: Partner Specific IMB
    partner-specific HIV risk reduction intervention
    Intervention: Behavioral: Partner-Specific IMB-based HIV risk reduction intervention
  • Placebo Comparator: HLS
    5 session psychoeducational group, designed to provide equivalent time and attention, that focuses on the importance of maintaining a good diet, exercise, and developing health skills.
    Intervention: Behavioral: Healthy Lifestyle
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
59
January 2011
January 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • English-speaking ability
  • unprotected vaginal, anal, or oral intercourse at least once in the 6 months prior to incarceration or placement
  • marijuana use disorders, other non-injection drug use disorders, or substance use by a sexual partner during a sexual episode in the six months prior to incarceration or placement
  • sentence or placement length between 2 and 12 months
  • must plan to remain in the area for the 6 months following their release from the facility
  • must be willing to provide two pieces of contact information for follow-up

Exclusion Criteria:

  • signs of psychosis (assessed through clinical assessment)
Both
15 Years to 18 Years   (Child, Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00831883
08-0128, R01DA022921-03
No
Not Provided
Not Provided
Cynthia Rosengard, Women and Infants Hospital of Rhode Island
Women and Infants Hospital of Rhode Island
University of Rhode Island
Principal Investigator: Cynthia Rosengard, PhD, MPH Women & Infants of Rhode Island
Women and Infants Hospital of Rhode Island
December 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP